AIMS testing is a standardized screening exam used to detect tardive dyskinesia, a movement disorder that can develop as a side effect of certain psychiatric medications. The full name is the Abnormal Involuntary Movement Scale, and it involves a clinician watching for involuntary movements in your face, mouth, limbs, and trunk. The exam is quick, typically taking less than 10 minutes, and is repeated every three to six months for people taking antipsychotic medications.
What AIMS Testing Screens For
Tardive dyskinesia (TD) is a condition marked by repetitive, involuntary movements that a person cannot control. It most commonly shows up as lip smacking, tongue thrusting, grimacing, or rapid blinking, but it can also involve jerky movements of the arms, legs, fingers, or torso. TD develops as a side effect of medications that block dopamine receptors in the brain, particularly antipsychotics used to treat conditions like schizophrenia, bipolar disorder, and severe depression.
The tricky part of TD is that it can creep in gradually. You might not notice the early signs yourself, and the movements can become permanent if they aren’t caught and addressed. That’s why routine screening matters. The AIMS exam exists not only to catch TD early but also to track its severity over time, giving clinicians a consistent way to measure whether movements are getting better, worse, or staying stable.
What Happens During the Exam
Before the exam begins, the clinician will ask you to remove anything from your mouth, such as gum or candy, since chewing can interfere with the assessment of involuntary jaw and tongue movements. You’ll typically be asked to remove your shoes as well so the examiner can observe your feet.
During the exam, you’ll sit in a chair while the clinician observes you through a series of simple tasks. These include sitting still with your hands on your knees, opening your mouth and sticking out your tongue, extending your arms in front of you, and walking across the room. The clinician is watching closely for any movements you aren’t doing on purpose: twitching in the cheeks, puckering of the lips, writhing of the tongue, fidgeting fingers, rocking of the trunk, or tapping feet. Some of these movements are subtle enough that they only appear during specific postures or activities, which is why the exam walks you through several positions rather than simply asking you to sit still.
How the Scoring Works
The AIMS is a 12-item scale. Ten items rate specific types of involuntary movement, and two items record dental status (whether you wear dentures or have missing teeth, since these affect how oral movements look). Each movement item is scored from 0 to 4, where 0 means no abnormal movement is observed and 4 means severe, continuous movement. A score of 1 represents minimal movement that may be at the extreme end of normal, while 2 and 3 reflect mild and moderate levels of clearly abnormal movement.
The body areas assessed fall into three groups: orofacial movements (muscles of the face, lips, jaw, and tongue), extremity movements (arms, hands, legs, and feet), and trunk movements (neck, shoulders, and hips). A positive screen for tardive dyskinesia generally requires at least one body area scoring a 2 (mild) or higher, or two or more areas each scoring at least 1. Clinicians use this pattern rather than a single total score because TD doesn’t affect every body region equally, and even mild movements in multiple areas can signal the condition’s onset.
Who Needs AIMS Testing
Anyone taking antipsychotic medication is a candidate for regular AIMS screening. The standard recommendation is every three to six months, though the frequency can vary based on your risk level. People taking older antipsychotics (sometimes called first-generation or typical antipsychotics) face a higher risk of developing TD than those on newer medications, so they may be screened more often. Other risk factors include older age, being female, having a mood disorder alongside the condition being treated, and longer duration of antipsychotic use.
AIMS testing isn’t limited to antipsychotics alone. Some anti-nausea medications and drugs used for gastrointestinal conditions also block dopamine and carry a TD risk, so people on those medications may undergo screening too.
How AIMS Differs From Other Movement Scales
The AIMS is one of three scales that are commonly used together when clinicians need a full picture of movement-related side effects from psychiatric medications. Each one targets a different problem. The AIMS focuses specifically on tardive involuntary movements. The Simpson-Angus Scale (SAS) measures drug-induced parkinsonism, which looks like stiffness, tremor, and slowed movement. The Barnes Akathisia Rating Scale (BARS) assesses akathisia, a distressing inner restlessness that makes it nearly impossible to sit still.
These three conditions can coexist in the same person, and they sometimes overlap in how they look from the outside. A person who appears fidgety might have akathisia, tardive dyskinesia, or both. Using all three scales together helps clinicians distinguish between them, which matters because the treatments are different.
What Your Results Mean in Practice
A normal AIMS result, with all items scored at 0, means no involuntary movements were detected at that visit. This doesn’t mean you’re permanently in the clear, which is why the screening repeats regularly for as long as you take the medication. TD can appear months or even years into treatment.
If the exam does pick up abnormal movements, your clinician will compare results across visits to see whether the movements are new, worsening, or stable. A single mildly elevated score might prompt closer monitoring, while a clear positive screen typically leads to a conversation about adjusting your medication. Options might include lowering the dose, switching to a different medication, or adding a treatment specifically aimed at reducing the involuntary movements. Early detection gives you the most flexibility, since TD is easier to manage and more likely to improve when caught before the movements become well established.
The exam itself is painless and noninvasive. There’s no blood draw, no imaging, and no preparation needed beyond removing gum from your mouth. If you’re taking a medication that carries TD risk and haven’t been screened, it’s reasonable to ask about it at your next appointment.